Research & Development



  打過之後,兩人之間的怨隙就抹平了。   霍光眨巴眨巴眼楮道︰“可你是我西北理工的弟子啊,你準備騙夏侯靜到什麼時候?”6701彩票app下载   趙破奴笑道︰“匈奴人知曉我們在後面追趕,所以就想盡辦法遲滯我大軍行程,雕蟲小技爾,不足為慮。”1933彩票app   等司馬相如走遠之後,夏侯靜冷冷的看著他的背影,無聲的笑了一下,將攤開的文書一一合起來,抱在懷中,去隋越那里繳令。   如果這一套法則在大漢國運行成了習慣,那麼,一個喜歡到處搜集好東西為自己用,又能保證自己的好東西不外傳的國家,變得富裕強大起來是必然之事。福利彩票软件下载   東方朔把玩著一顆晶瑩剔透屁的玉石籽料道︰“這是宦囊!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo